2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Multicentre point-prevalence survey of antibiotic use and healthcare-associated infections in Ethiopian hospitals

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          Effective antimicrobial containment strategies such as Antimicrobial Stewardship Programs (ASPs) require comprehensive data on antibiotics use which are scarce in Ethiopia. This study sought to assess antibiotics use and healthcare-associated infections (HCAIs) in Ethiopian public hospitals.

          Design

          We conducted a cross-sectional study using the WHO point-prevalence survey protocol for systemic antibiotics use and HCAIs for low/middle-income countries.

          Setting

          The study was conducted among 10 public hospitals in 2021.

          Participants

          All patients admitted to adult and paediatric inpatient and emergency wards before or at 08:00 on the survey date were enrolled.

          Outcome measure

          The primary outcome measures were the prevalence of antibiotic use, HCAIs and the hospitals’ readiness to implement ASP.

          Results

          Data were collected from 1820 patient records. None of the surveyed hospitals had functional ASP. The common indication for antibiotics was for HCAIs (40.3%). Pneumonia was the most common bacterial infection (28.6%) followed by clinical sepsis (17.8%). Most treatments were empiric (96.7%) and the overall prevalence of antibiotic use was 63.8% with antibiotics prescription per patient ratio of 1.77. Ceftriaxone was the most commonly prescribed antibiotic (30.4%) followed by metronidazole (15.4%). Age, having HIV infection, ward type, type of hospital, catheterisation and intubation history had significant association with antibiotic use. Patients who were treated in paediatric surgical wards were about four times more likely to be on antibiotics compared with patients treated at an adult emergency ward. Patients on urinary catheter (adjusted OR (AOR)=2.74, 95% CI: 2.04 to 3.68) and intubation device (AOR=2.62, 95% CI: 1.02 to 6.76) were more likely to be on antibiotics than their non-intubated/non-catheterised counterparts. Patients treated at secondary-level hospitals had 0.34 times lower odds of being on antibiotics compared with those in tertiary hospitals.

          Conclusions

          Antibiotic use across the surveyed hospitals was common and most were empiric which has both practical and policy implications for strengthening ASP and promoting rational antibiotics use.

          Related collections

          Most cited references42

          • Record: found
          • Abstract: found
          • Article: not found

          Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017.

          The human and financial costs of treating surgical site infections (SSIs) are increasing. The number of surgical procedures performed in the United States continues to rise, and surgical patients are initially seen with increasingly complex comorbidities. It is estimated that approximately half of SSIs are deemed preventable using evidence-based strategies.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            The threat of antimicrobial resistance in developing countries: causes and control strategies

            The causes of antimicrobial resistance (AMR) in developing countries are complex and may be rooted in practices of health care professionals and patients’ behavior towards the use of antimicrobials as well as supply chains of antimicrobials in the population. Some of these factors may include inappropriate prescription practices, inadequate patient education, limited diagnostic facilities, unauthorized sale of antimicrobials, lack of appropriate functioning drug regulatory mechanisms, and non-human use of antimicrobials such as in animal production. Considering that these factors in developing countries may vary from those in developed countries, intervention efforts in developing countries need to address the context and focus on the root causes specific to this part of the world. Here, we describe these health-seeking behaviors that lead to the threat of AMR and healthcare practices that drive the development of AMR in developing countries and we discuss alternatives for disease prevention as well as other treatment options worth exploring.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the Future

              This article gives a very brief overview of the antibiotic era, beginning from the discovery of first antibiotics until the present day situation, which is marred by the emergence of hard-to-treat multiple antibiotic-resistant infections. The ways of responding to the antibiotic resistance challenges such as the development of novel strategies in the search for new antimicrobials, designing more effective preventive measures and, importantly, better understanding the ecology of antibiotics and antibiotic resistance are discussed. The expansion of conceptual frameworks based on recent developments in the field of antimicrobials, antibiotic resistance, and chemotherapy is also discussed.
                Bookmark

                Author and article information

                Journal
                BMJ Open
                BMJ Open
                bmjopen
                bmjopen
                BMJ Open
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                2044-6055
                2022
                11 February 2022
                : 12
                : 2
                : e054541
                Affiliations
                [1 ]departmentSchool of Pharmacy, Department of Pharmacology and Clinical Pharmacy , Addis Ababa University, College of Health Sciences , Addis Ababa, Ethiopia
                [2 ]departmentPharmaceuticals and Medical Equipment Directorate , Ethiopia Ministry of Health , Addis Ababa, Ethiopia
                [3 ]World Health Organization Ethiopia Office , Addis Ababa, Ethiopia
                [4 ]departmentCollege of Pharmacy , Purdue University , West Lafayette, Indiana, USA
                [5 ]departmentSchool of Medicine , Indiana University , Indianapolis, Indiana, USA
                [6 ]departmentInstitute of Health Policy Management and Evaluation , University of Toronto , Toronto, Ontario, Canada
                [7 ]departmentToronto Health Economics and Technology Assessment (THETA) Collaborative , University Health Network , Toronto, Ontario, Canada
                Author notes
                [Correspondence to ] Atalay Mulu Fentie; atalay.mulu@ 123456aau.edu.et

                EA and GBG are joint senior authors.

                Author information
                http://orcid.org/0000-0001-6065-0695
                http://orcid.org/0000-0001-7078-1904
                Article
                bmjopen-2021-054541
                10.1136/bmjopen-2021-054541
                8845215
                35149567
                0c52908b-1caa-4e93-93c4-c13daa8fed9d
                © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

                This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:  http://creativecommons.org/licenses/by-nc/4.0/.

                History
                : 15 June 2021
                : 31 January 2022
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100007855, Alliance for Health Policy and Systems Research;
                Award ID: NA
                Funded by: National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award;
                Award ID: KL2TR002530 (B. Tucker Edmonds, PI)
                Award ID: UL1TR002529 (S. Moe and S. Wiehe, co-PIs)
                Categories
                Infectious Diseases
                1506
                1706
                Original research
                Custom metadata
                unlocked

                Medicine
                infectious diseases,public health,health policy,quality in health care
                Medicine
                infectious diseases, public health, health policy, quality in health care

                Comments

                Comment on this article